Below are the most recent publications written about "Uganda" by people in Profiles.
-
Buhikire K, Voss J, Kigozi J, Nyakato P, Ankunda N, Kalebbo B, Musiitwa M, Muganzi A, Sewankambo NK, Nakanjako D. Reaching the First 90 in Uganda: Predictors of Success in Contacting and Testing the Named Sexual Partners of HIV+ Index Clients in Kiboga District. AIDS Behav. 2018 Aug; 22(8):2458-2467.
-
Kawooya MG, Goldberg BB, De Groot W, Matovu PD, Malwadde EK, Baltarowich OH. Evaluation of US training for the past 6 years at ECUREI, the World Federation for Ultrasound in Medicine and Biology (WFUMB) Centre of Excellence, Kampala, Uganda. Acad Radiol. 2010 Mar; 17(3):392-8.
-
Castelnuovo B, John L, Lutwama F, Ronald A, Spacek LA, Bates M, Kamya MR, Colebunders R. Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity. J Int Assoc Physicians AIDS Care (Chic). 2009 Jan-Feb; 8(1):52-9.
-
Lutwama F, Serwadda R, Mayanja-Kizza H, Shihab HM, Ronald A, Kamya MR, Thomas D, Johnson E, Quinn TC, Moore RD, Spacek LA. Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy. J Acquir Immune Defic Syndr. 2008 Jul 01; 48(3):297-303.
-
Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, Castelnuovo B, Schaefer P, Spacek LA, Gasasira AF, Katabira E, Colebunders R, Quinn TC, Ronald A, Thomas DL, Kekitiinwa A. Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2007 Oct 01; 46(2):187-93.
-
Spacek LA, Shihab HM, Lutwama F, Summerton J, Mayanja H, Kamya M, Ronald A, Margolick JB, Nilles TL, Quinn TC. Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and Uganda. J Acquir Immune Defic Syndr. 2006 Apr 15; 41(5):607-10.
-
Spacek LA, Gray RH, Wawer MJ, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Kiwanuka N, Kigozi G, Nalugoda F, Quinn TC. Clinical illness as a marker for initiation of HIV antiretroviral therapy in a rural setting, Rakai, Uganda. Int J STD AIDS. 2006 Feb; 17(2):116-20.
-
Spacek LA, Shihab HM, Kamya MR, Mwesigire D, Ronald A, Mayanja H, Moore RD, Bates M, Quinn TC. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clin Infect Dis. 2006 Jan 15; 42(2):252-9.
-
Kamya MR, Semitala FC, Quinn TC, Ronald A, Njama-Meya D, Mayanja-Kizza H, Katabira ET, Spacek LA. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda. Afr Health Sci. 2004 Aug; 4(2):94-101.